Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?

H Liu, Y Zhang, L Li, J Cao, Y Guo, Y Wu… - Molecular Therapy …, 2021 - cell.com
Fascin actin-bundling protein 1 (FSCN1) is a highly conserved actin-bundling protein that
cross links F-actin microfilaments into tight, parallel bundles. Elevated FSCN1 levels have …

Fascin in cell migration: more than an actin bundling protein

MC Lamb, TL Tootle - Biology, 2020 - mdpi.com
Simple Summary Cell migration is an essential biological process that regulates both
development and diseases, such as cancer metastasis. Therefore, understanding the factors …

Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway

Q Xie, Z Yang, X Huang, Z Zhang, J Li, J Ju… - Journal of Hematology & …, 2019 - Springer
Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast
cancer with poor prognosis, and its treatment remains a challenge due to few targeted …

[HTML][HTML] FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance

Z Li, J Shi, N Zhang, X Zheng, Y Jin, S Wen… - Journal of …, 2022 - ncbi.nlm.nih.gov
Fascin actin-bundling protein 1 (FSCN1) is an actin-bundling protein that is capable of
inducing membrane protrusions and plays critical roles in cell migration, motility, adhesion …

New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells

B Alburquerque-González, M Bernabé-García… - … & Molecular Medicine, 2020 - nature.com
Serrated adenocarcinoma (SAC) is more invasive, has worse outcomes than conventional
colorectal carcinoma (CRC), and is characterized by frequent resistance to anti-epidermal …

Sphingosine kinase 1 signaling promotes metastasis of triple-negative breast cancer

S Acharya, J Yao, P Li, C Zhang, FJ Lowery, Q Zhang… - Cancer research, 2019 - AACR
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype. To
identify TNBC therapeutic targets, we performed integrative bioinformatics analysis of …

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer

CQ Wang, CH Tang, HT Chang, XN Li… - Cancer …, 2016 - Wiley Online Library
In some cases of breast cancer, diagnosis of triple‐negative breast cancer (TNBC) requires
further fluorescence in situ hybridization (FISH) for determining human epidermal growth …

EGFR conjunct FSCN1 as a novel therapeutic strategy in triple-negative breast cancer

CQ Wang, Y Li, BF Huang, YM Zhao, H Yuan, D Guo… - Scientific reports, 2017 - nature.com
Emerging evidence indicates that Fascin-1 (FSCN1) may possess a causal role in the
development of several types of cancers and serves as a novel biomarker of aggressiveness …

FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer

CQ Wang, CH Tang, Y Wang, L Jin, Q Wang, X Li… - Scientific reports, 2017 - nature.com
Breast cancer is a major cause of cancer mortality worldwide. Fascin-1 (FSCN1) is an actin-
binding protein found in mammalian cells, including endothelial, neuronal and …

Antitumoral effects of tricyclic antidepressants: beyond neuropathic pain treatment

A Asensi-Cantó, MD López-Abellán… - Cancers, 2022 - mdpi.com
Simple Summary Tricyclic antidepressants (TCAs) are old and known therapeutic agents
whose good safety profile makes them good candidates for drug repurposing. As the …